Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 billion
Compare this $65 billion figure to previous annual revenues (only in the millions, not billions)
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 billion
Compare this $65 billion figure to previous annual revenues (only in the millions, not billions)